Lataa...

Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer

BACKGROUND: Colorectal cancer is the third most common cancer and a major cause of morbidity and mortality worldwide. Adjuvant chemotherapy is considered the standard of care in patients with UICC stage III colon cancer after R0 resection. Adjuvant therapy was not shown to be beneficial in patients...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Cancer
Päätekijät: Teufel, Andreas, Gerken, Michael, Hartl, Janine, Itzel, Timo, Fichtner-Feigl, Stefan, Stroszczynski, Christian, Schlitt, Hans Jürgen, Hofstädter, Ferdinand, Klinkhammer-Schalke, Monika
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2015
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4451874/
https://ncbi.nlm.nih.gov/pubmed/25985893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1404-9
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!